Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 5.70
-0.05 (-0.87%)
At close: Oct 6, 2026
Labiana Health Market Cap
Labiana Health has a market cap or net worth of €47.3 million as of October 6, 2026. Its market cap has increased by 56.25% in one year.
Market Cap
47.30M
Enterprise Value
77.09M
Revenue
76.44M
Ranking
n/a
PE Ratio
15.60
Stock Price
€5.70
ChartMarket Cap Chart
Since June 24, 2022, Labiana Health's market cap has increased from 33.22M to 47.30M, an increase of 42.41%. That is a compound annual growth rate of 8.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 47.30M | 39.72% |
| Dec 31, 2025 | 33.86M | 62.46% |
| Dec 31, 2024 | 20.84M | 134.14% |
| Dec 29, 2023 | 8.90M | -63.32% |
| Dec 30, 2022 | 24.26M | -26.96% |
| Jun 24, 2022 | 33.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 2.92B |
| Almirall | 2.23B |
| Faes Farma | 1.44B |
| Oryzon Genomics | 223.92M |
| Laboratorio Reig Jofre | 215.04M |
| Prim, S.A. | 214.30M |
| Atrys Health | 195.46M |